These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 38279329)

  • 21. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
    Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
    Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?
    Rodrigues PB; Dos Santos Pereira Gomes AB; Genaro LM; Pascoal LB; de Souza APD; Leal RF; Vinolo MAR
    Adv Exp Med Biol; 2021; 1327():93-106. PubMed ID: 34279831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of the gut microbiota in severe SARS-CoV-2 infection.
    Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
    Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics.
    Sapra L; Saini C; Garg B; Gupta R; Verma B; Mishra PK; Srivastava RK
    Inflamm Res; 2022 Sep; 71(9):1025-1040. PubMed ID: 35900380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metagenomic analysis of RNA sequencing data reveals SARS-CoV-2-mediated progressive dysbiosis of upper respiratory tract microbiota.
    Velmurugan G; Vasudevan D
    Biomed J; 2021 Aug; 44(4):504-507. PubMed ID: 34507920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19: Is there a role for immunonutrition in obese patient?
    Di Renzo L; Gualtieri P; Pivari F; Soldati L; Attinà A; Leggeri C; Cinelli G; Tarsitano MG; Caparello G; Carrano E; Merra G; Pujia AM; Danieli R; De Lorenzo A
    J Transl Med; 2020 Nov; 18(1):415. PubMed ID: 33160363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study.
    Zhang L; Xu Z; Mak JWY; Chow KM; Lui G; Li TCM; Wong CK; Chan PKS; Ching JYL; Fujiwara Y; Chan FKL; Ng SC
    J Gastroenterol Hepatol; 2022 May; 37(5):823-831. PubMed ID: 35170078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity.
    Gutiérrez-Díaz I; Sanz-Martinez M; Castro AM; Rodríguez-Belvís MV; Carreira N; Jiménez S; Mangas C; Queralt M; Herrador M; Martín-Masot R; Ferrer P; Navas-López VM; Espín B; Leis R; Díaz JJ; Delgado S
    Eur J Pediatr; 2023 Oct; 182(10):4633-4645. PubMed ID: 37555973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
    Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E
    Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes.
    Chen J; Vitetta L
    Front Biosci (Schol Ed); 2022 Aug; 14(3):23. PubMed ID: 36137978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection.
    Trottein F; Sokol H
    Cell Rep; 2020 Jul; 32(3):107915. PubMed ID: 32649864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link?
    Balmant BD; Torrinhas RS; Rocha IM; Fonseca DC; Formiga FFC; Bonfá ESDO; Borba EF; Waitzberg DL
    Nutrition; 2021 May; 85():111115. PubMed ID: 33545540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiota and COVID-19: Long-term and complex influencing factors.
    Gang J; Wang H; Xue X; Zhang S
    Front Microbiol; 2022; 13():963488. PubMed ID: 36033885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary intervention with functional foods modulating gut microbiota for improving the efficacy of COVID-19 vaccines.
    Oh S; Seo H
    Heliyon; 2023 May; 9(5):e15668. PubMed ID: 37124341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions.
    Wang B; Zhang L; Wang Y; Dai T; Qin Z; Zhou F; Zhang L
    Signal Transduct Target Ther; 2022 Apr; 7(1):143. PubMed ID: 35487886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution.
    Ferreira-Junior AS; Borgonovi TF; De Salis LVV; Leite AZ; Dantas AS; De Salis GVV; Cruz GNF; De Oliveira LFV; Gomes E; Penna ALB; De Oliveira GLV
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role of the microbiome in liver injury during COVID-19: Further research is needed.
    Tovani-Palone MR; Pedersini P
    World J Gastroenterol; 2023 Jan; 29(3):503-507. PubMed ID: 36688015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.